Formation | 2002 |
---|---|
Founder | Luigi Naldi |
Type | non-profit |
Legal status | Association |
Purpose | Clinical and epidemiological research, education and assistance in dermatology |
Headquarters | Bergamo (Italy) |
President | Vincenzo Bettoli |
Website | https://www.centrostudigised.it/en/ |
Centro Studi GISED is an Italian research association with legal personality registered with no. 2096/2004 at the R.E.A. Register in Bergamo (Italy). It is a non-profit association established in 2002, and it develops research and educational programs with the aim of improving scientific knowledge, assistance and transparent and specific information to the public with regard to the main dermatological diseases.
The Italian Group for Epidemiological Research in Dermatology (GISED) was set up within the Italian Society of Dermatology and Venereology (formerly SIDEV, now SIDEMAST) in 1986 as a working group focusing on epidemiological research. It was a joint initiative of Prof. Tullio Cainelli, director of the Department of Dermatology, University of Milan at Ospedali Riuniti of Bergamo, and Prof. Alfredo Rebora, director of the Department of Dermatology, University of Genoa. In the Scientific Committee were involved. Prof. Giuseppe Zina, director of the Department of Dermatology, University of Turin, and Dr. Gianni Tognoni of the Mario Negri Institute for Pharmacological Research. Dr. Luigi Naldi, at that time a young investigator at the Laboratory of Clinical Pharmacology of the Mario Negri Institute in Milan, was the person in charge of the organization of the coordinating centre. The headquarters of the coordinating centre had been located for several years, until March 2009, at the Dermatology Unit of Ospedali Riuniti of Bergamo.
Since its founding in 1986, GISED grew progressively. Its activities ranged over the years from descriptive epidemiology to etiological research, randomized clinical trials, registers, and systematic reviews. [1] [2] [3] A total of 50 academic and clinical centres contributed to these projects. Over the years, formal courses on research methodology and on Evidence Based Medicine were also organized. Overall, GISED proved to be not only an effective collaborative network but also a valuable tool for education and dissemination of an epidemiological and methodological culture. Over the years, several contacts have been established at the international level (among the others, the EuroSCAR and RegiSCAR networks, the European Dermato-Epidemiology Network (EDEN), the Cochrane Collaboration).
A limiting factor for further possible development of GISED activities was the lack of a formal structure and legal basis for the coordinating centre. For this reason, in 2002, the Centro Studi GISED association was founded. Dr. Luigi Naldi was elected president, assisted by a scientific Board composed by the most active members of the group. In 2003, Centro Studi GISED got formal recognition as a non-profit association by the Lombardy Region and was registered in the Register of Companies (REA) with the n. 2096. Again in 2003, an agreement with the Inter-University Centre Thomas Chalmers at the University of Milan was signed and Centro Studi GISED became a component of the Italian Cochrane Network.
Besides coordinating the research projects of the GISED network, Centro Studi GISED began to develop its own projects with particular attention to clinical research, combination of basic research and clinical research (translational research), imaging and information techniques in dermatology. [4] [5] [6] [7] [8] In 2008, GISED ceased to be a working group of SIDEMAST and was maintained as an informal group of people interested in working in multi-centre studies, the "GISED network". The headquarters of the Association were at Ospedali Riuniti of Bergamo until March 2009, when they moved to the Matteo Rota Hospital, collaborating with the newly formed Research Foundation Ospedale Maggiore of Bergamo (FROM). From 2009 to 2011 another office, primarily dedicated to the development of innovative imaging systems in dermatology, was activated at the Kilometro Rosso Science and Technology Park in Stezzano. In March 2018, Centro Studi GISED moved its headquarters to via Clara Maffei 4 in Bergamo, at the officies made available by the Health Protection Agency (ATS) of Bergamo.
Psoriasis is a long-lasting, noncontagious autoimmune disease characterized by raised areas of abnormal skin. These areas are red, pink, or purple, dry, itchy, and scaly. Psoriasis varies in severity from small localized patches to complete body coverage. Injury to the skin can trigger psoriatic skin changes at that spot, which is known as the Koebner phenomenon.
Pityriasis rosea is a type of skin rash. Classically, it begins with a single red and slightly scaly area known as a "herald patch". This is then followed, days to weeks later, by an eruption of many smaller scaly spots; pinkish with a red edge in people with light skin and greyish in darker skin. About 20% of cases show atypical deviations from this pattern. It usually lasts less than three months and goes away without treatment. Sometimes malaise or a fever may occur before the start of the rash or itchiness, but often there are few other symptoms.
Galderma S.A. is a Swiss pharmaceutical company specializing in dermatological treatments and skin care products. Formerly a subsidiary of L'Oréal and Nestlé, it has been held by a consortium of private institutional investors since 2019.
The University of Bergamo is an Italian public university located in Bergamo, Italy. It was founded on 11 December 1968 and is organized in seven departments, three campuses and forty-one degree courses.
The International Federation of Rock Art Organizations (IFRAO) is a coordinating body of 60 organizations concerned with prehistoric rock art.
Muir–Torre syndrome is a rare hereditary, autosomal dominant cancer syndrome that is thought to be a subtype of HNPCC. Individuals are prone to develop cancers of the colon, genitourinary tract, and skin lesions, such as keratoacanthomas and sebaceous tumors. The genes affected are MLH1, MSH2, and more recently, MSH6, and are involved in DNA mismatch repair.
In medicine, a finger tip unit (FTU) is defined as the amount of ointment, cream or other semi-solid dosage form expressed from a tube with a 5 mm diameter nozzle, applied from the distal skin-crease to the tip of the index finger of an adult. The "distal skin-crease" is the skin crease over the joint nearest the end of the finger. One FTU is enough to treat an area of skin twice the size of the flat of an adult's hand with the fingers together, i.e. a "handprint". Two FTUs are approximately equivalent to 1 g of topical steroid.
The Mario Negri Institute for Pharmacological Research is a nonprofit research institute dedicated to clinical and biomedical research. It was made possible by a special bequest of Milan philanthropist Mario Negri. It was founded in 1961 although it started working in Milan from 1st Feb 1963. There are branches of the institute in Bergamo, Ranica (BG), and at Santa Maria Imbaro, near Chieti.
Y Touring Theatre Company was a national touring theatre company which produced original plays and debates exploring contemporary issues. It was founded in 1989 by Nigel Townsend. The company was based in Kings Cross, London, England and was a former operation of Central YMCA.
Mark G. Lebwohl is an American dermatologist and author who is Professor and Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology and the Dean for Clinical Therapeutics at the Icahn School of Medicine at Mount Sinai in New York City.
Vittorio Cotesta - Roccagorga (LT) is an Italian social scientist. At present he is conducting research into global society, cosmopolitism and human rights, sociological theories, cultures, civilizations and ethnic conflict.
Louis Dubertret was born on 18 June 1943 in Douai, France. He had a distinctive career as an associate professor specializing in dermatology and cutaneous biology, is now a Professor Emeritus, and currently serves as the president of the René Touraine Foundation.
The Association for International and Comparative Studies in Labour and Industrial Relations (ADAPT) is a non-profit organization that conducts and supports academic research in the field of labour and industrial relations.
The Psoriasis Index of Quality of Life (PSORIQoL) is a patient-reported outcome measure which determines the quality of life of patients with psoriasis. It is based on a needs-based approach to quality of life.
Nicholas J Lowe is an English dermatologist who has published research into skin pharmacology, botulinum toxins, injectable filler and Lasers in cutaneous and cosmetic Surgery.
The Dermatology life Quality Index (DLQI) is a ten-question questionnaire used to measure the impact of skin disease on the quality of life of an affected person. It is designed for people aged 16 years and above.
The Organisation of European Cancer Institutes (OECI) is an international non-profit organization with European Economic Interest Grouping status. It was created in 1979 to promote greater cooperation among European cancer centers and institutes. Its head office is located in Brussels at the Belgian University Foundation.
Lajos Kemény is a Hungarian dermatologist, venereologist, allergologist, medical researcher, full professor and the Head of the Department of Dermatology and Allergology, the director of the Albert Szent-Györgyi Health Center, Faculty of Medicine, University of Szeged and the Vice-Rector for Science, Research Development and Innovation. He is a notable and respected scientist both in Hungary and around the world.
Christopher Ernest Maitland Griffiths is Foundation Professor of Dermatology at the University of Manchester, Director of the Manchester Centre for Dermatology Research, and Head of the Dermatology Theme of the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre. He is an Honorary Consultant Dermatologist at Salford Royal NHS Foundation Trust.
Joel M. Gelfand is an American dermatologist and epidemiologist at the University of Pennsylvania in Philadelphia, Pennsylvania. He currently serves as the James J. Leyden Professor in Clinical Investigation, the Vice Chair of Clinical Research, the director of the Psoriasis and Phototherapy Treatment Center, and the medical director of the Clinical Studies Unit in the Department of Dermatology at the Perelman School of Medicine at the University of Pennsylvania. He studies systemic comorbidities of psoriasis and much of his research has centered on the connection between cardiovascular disease and psoriasis.